Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia

Transplantation. 1985 Jun;39(6):671-3.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anemia, Aplastic / therapy*
  • Antilymphocyte Serum / administration & dosage*
  • Blood Transfusion
  • Bone Marrow Transplantation*
  • Cyclophosphamide / administration & dosage*
  • Drug Therapy, Combination
  • Graft Rejection / drug effects*
  • Graft vs Host Disease / prevention & control
  • Humans
  • Procarbazine / administration & dosage*
  • T-Lymphocytes / immunology

Substances

  • Antilymphocyte Serum
  • Procarbazine
  • Cyclophosphamide